Acetylcholinesterase activity and oxidative stress indices in cerebellum, cortex and hippocampus of rats exposed to lead and manganese

  • Abstract
  • Keywords
  • References
  • PDF
  • Abstract

    Human exposure to metals is a major health concern in the world as a result of increased industrialization. The present study was designed to investigate the toxic effect of lead and manganese alone and in combination on different regions of rat brain, namely cerebellum, cortex and hippocampus. Adult male Wistar rats were exposed to 100 ppm lead as lead acetate, 100 ppm manganese as manganese chloride, and lead and manganese in combination in their drinking water for 4 weeks. Following either lead or manganese exposure, acetylcholinesterase activity and the antioxidant enzymes, superoxide dismutase and catalase activities were inhibited. Likewise, malonylaldehyde level, a marker of lipid peroxidation and protein carbonyl groups used to assess oxidatively modified proteins were markedly increased by exposure to either metals. The non-enzymatic antioxidants, reduced glutathione and total thiol groups were significantly (p < 0.05) depleted by these metals. However, these aspects were more pronounced in animals exposed to the mixture of both lead and manganese. The metals displayed additive, as well as, potentiation effect in their interactions in the brain regions. It can thus, be concluded that the mixture of lead and manganese demonstrated a higher neurotoxic effects than does either metals alone.

  • Keywords

    Lead; Manganese; Coexposure; Brain Regions; Acetylcholinesterase; Oxidative Stress.

  • References

      [1] Adonaylo VN & Oteiza PI (1999) Lead intoxication: antioxidant defenses and oxidative damage in rat brain. Toxicology 135, 77–85.

      [2] Aitken RJ & Roman SD (2008) Antioxidant systems and oxidative stress in the testes. In: Cheng CY, (ed.) Molecular mechanisms in spermatogenesis. Landes Bioscience and Springer Science+ Business Media, New York, pp. 154–171.

      [3] Al-Harbi NY (2013) Histological alteration induced by manganese chloride in the male testes, epididymis and kidney of the albino rats. Journal of Pharmacy and Biological Sciences 4(6), 5-8.

      [4] Andrade V, Mateus ML, Batoréu MC, Aschner M & Marreilha dos Santos AP (2013) Urinary delta-ALA: a potential biomarker of exposure and neurotoxic effect in rats co-treated with a mixture of lead, arsenic and manganese. NeuroToxicology 38, 33–41.

      [5] Andreasen NC, Nopoulos P, O’Leary DS, Miller DD, Wassink T & Flaum M (1999) Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biological Psychiatry 46(7), 908–920.

      [6] Antonio MT, Corredor L & Leret ML (2003) Study of the activity of several brain enzymes like markers of the neurotoxicity induced by perinatal exposure to lead and/or cadmium. Toxicology Letter 143, 331- 340.

      [7] Aschner M (2006) the transport of manganese across the blood-brain barrier. NeuroToxicology 27, 311–314.

      [8] Agency for Toxic Substances and Disease Registry (2007) Toxicological profile for manganese. U.S. Department of Health and Human Services, Public Health Service.

      [9] Balbuena P, Li W & Ehrich M (2011) Assessments of tight junction proteins occludin, claudin 5 and scaffold proteins ZO1 and ZO2 in endothelial cells of the rat blood–brain barrier: Cellular responses to neurotoxicants malathion and lead acetate. NeuroToxicology 32, 58–67.

      [10] Beutler E, Duron O & Kelly BM (1963) Improved method for the determination of blood glutathione. Journal of Laboratory and Clinical Medicine 61, 882–888.

      [11] Bokara KK, Brown E, McCormick R, Yallapragada PR, Rajanna S & Bettaiya R (2008) Lead-induced increase in antioxidant enzymes and lipid peroxidation products in developing rat brain. Biometals 21, 9–16.

      [12] Bondy SC (1997) Free Radical Toxicology, Taylor and Francis, Oxford.

      [13] Bressler J, Kim KA, Chakraborti T &Goldstein G. (1999) Molecular mechanisms of lead neurotoxicity. Neurochemical Research 24,595–600.

      [14] Budowski P, Leighfield, MJ and Crawford MA. (1987) Nutritional encephalomalacia in the chick: an exposure of the vulnerable period for cerebellar development and the possible need for both w6- and w3-fatty acids. British Journal of Nutrition. 58: 511–520.

      [15] Buege, JA & Aust D (1978) Microsomal lipid peroxidation method. Enzymology 52:302–310.

      [16] Chandra SV, Ali MM, Saxena DK & Murthy RC (1981) Behavioral and neurochemical changes in rats simultaneously exposed to manganese and lead. Archives of Toxicology 49(1), 49–56.

      [17] Chandra SV, Mohd M, Saxena DK and Murthy RC. (1981) Behavioral and Neurochemical Changes in Rats Simultaneously Exposed to Manganese and Lead. Archives of Toxicology. 49: 49–56.

      [18] Clairborne A (1985) Handbook of methods for oxygen radical research. Boca Raton, FL: CRC Press.

      [19] Cory-Slechta DA, Thiruchelvam M, Barlow BK & Richfield EK (2005) Developmental pesticide models of the Parkinson disease phenotype. Environmental Health Perspective. 113, 1263–1270.

      [20] De Rosa CT, El-Masri HA, Pohl H, Cibulas W & Mumtaz MM (2004) Implications of chemical mixtures in public health practice. Journal of Toxicology and Environmental Health, Part B: Critical Reviews. 7(5), 339–350.

      [21] Dhatrak SV & Nandi SS (2009) Risk assessment of chronic poisoning among Indian metallic miners. Indian Journal of Occupational and Environmental Medicine 13(2), 60–64.

      [22] Dringen R, Gutterer JM & Hirrlinger J (2000) Glutathione metabolism in brain: metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species. European Journal of Biochemistry 267, 4912-4916.

      [23] Ecobichon DJ (1996) Toxic effects of pesticides. In: Klaassen CD, Doull J (eds) Casarett and Doull’s toxicology: the basic science of poisons, 5th edn. McGraw-Hill, New York.

      [24] Ellman GL, Courtney KD, Andres V & Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemistry and Pharmacology. 7, 88–95.

      [25] Ellman GL (1959) Tissue sulphydryl groups. Archives of Biochemistry and Biophysics. 82, 70-77.

      [26] Flora SJ, Mehta A, Satsangi K, Kannan GM & Gupta M (2003) Aluminum-inducedvoxidative stress in rat brain: response to combined administrationvof citric acid and HEDTA. Comparative Biochemistry and Physiology Part C: Toxicology and Pharmacology 134, 319–328.

      [27] Griffiths D, Dickinson A & Clayton N (1999) Episodic memory: what can animals remember about their past? Trends in Cognitive Sciences. 3, 74–80.

      [28] Halliwell B (2006) Oxidative stress and neurodegeneration: Where are we now? Journal of Neurochemistry. 97, 1634-1658.

      [29] Hodgson EA (2010) Textbook of Modern Toxicology. 4th Edition. John Wiley and Sons, Inc.

      [30] Huang CC (2007) Parkinsonism induced by chronic manganese intoxication–an experience in Taiwan. Chang Gung Medical Journal. 30, 385–395.

      [31] Jemiola-Rzeminska M, Rivera C, Suwalsky M & Strzalka K (2007) Interaction of arsenic compounds with model phospholipid membranes. Thermochimica Acta 458, 132–137.

      [32] Jiang Y & Zheng W (2005) Cardiovascular toxicities upon manganese exposure. Cardiovascular Toxicology. 5, 345-54.

      [33] Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S & Stadtman ER (1990) Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 186, 464-478.

      [34] Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265– 275.

      [35] Lyn Patrick D (2003) Toxic metals and antioxidants: Part II. The role of antioxidants in arsenic and cadmium toxicity. Alternative Medicine Review 8, 106- 128.

      [36] Mellard D, Johnson M & Mumtaz M (2011) Principles and practice of mixtures toxicology. John Wiley & Sons.

      [37] Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA & Shelton MD (2008) Molecular mechanisms and clinical implications of reversible protein S-glutathionylation. Antioxidants & Redox Signaling 10(11), 1941–1988.

      [38] Misra HP & Fridovich I (1972) the role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. Journal of Biological Chemistry 247, 3170–3175.

      [39] Moron MS, Desperre JW & Minnervik B (1979) Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta. 582, 67-78.

      [40] Nakade UP, Garq SK, Sharma A, Choudhury S, Yadav RS, Gupta K & Sood N (2015) Lead-induced adverse effects on the reproductive system of rats with particular reference to histopathological changes in uterus. Indian Journal of Pharmacology 47(1), 22–26.

      [41] Normandin L, Beaupre LA, Salehi F, St.-Pierre A, Kennedy G, Mergler D, Butterworth RF, Philippe LA & Zayed J (2004) Manganese distribution in the brain and neurobehavioral changes following inhalation exposure of rats to three chemical forms of manganese. NeuroToxicology 25, 433–41.

      [42] Oddo S & LaFerla FM (2006) the role of nicotinic acetylcholine receptors in Alzheimer’s disease. Journal of Physiology-Paris. 99, 172–179.

      [43] Ohkawa H, Ohishi N & Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry. 95, 351–358. (79)90738-3.

      [44] Olney JW, Collins RC & Sloviter RS (1986) Excitotoxic mechanisms of epileptic brain damage. Advances in Neurology 44, 857–877.

      [45] Perry EK & Perry RH (1980) Biochemistry of dementia. John Wiley & Sons, Chichester.

      [46] Pratico D & Delanty N (2000) Oxidative injury in diseases of the central nervous system: focus on Alzheimer’s disease. The American Journal of Medicine 109, 577–585.

      [47] Rodriguez VM, Dufour L, Carrizales L, Diaz-Barriga F & Jimenez-Capdeville ME (1998) Effects of oral exposure to mining waste on in vivo dopamine release from rat striatum. Environmental Health Perspectives 106(8), 487–491.

      [48] Shukla A, Shukla GS & Srimal RC (1996) Cadmium-induced alterations in blood-brain barrier permeability microvessel antioxidant potential in rat. Human and Experimental Toxicology 15, 400-405.

      [49] Stepens A, Logina I, Liguts V, Aldins P, Eksteina I, Platkajis A, Martinsone I, Terauds E, Rozentale B & Donaghy M. (2008) A Parkinsonian syndrome in methcathinone users and the role of manganese. New England Journal of Medicine. 358, 1009–1017.

      [50] Stuss DT & Alexander MP (2000) Executive functions and the frontal lobes: a conceptual view. Psychological Research 63, 289–298.

      [51] Toscano CD & Guilarte TR (2005) Lead neurotoxicity: From exposure to molecular effects. Brain Research Reviews 49: 529–554.

      [52] Weiss B (2011) Lead, manganese, and methylmercury as risk factors for neurobehavioral impairment in advanced age. International Journal of Alzheimer’s disease. 2011, 607543.

      [53] Yang RSH (2016) Toxicology of Chemical Mixtures: Case Studies, Mechanisms, and Novel Approaches. Elsevier.

      [54] Yokel RA (2009) Manganese flux across the blood-brain barrier. Neuromolecular Medicine 11(4), 297– 310.




Article ID: 6459
DOI: 10.14419/ijbr.v4i2.6459

Copyright © 2012-2015 Science Publishing Corporation Inc. All rights reserved.